ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0756

Validation of Quantitative Effusion-synovitis Volume Measured by Deep-learning: Data from the Osteoarthritis Initiative

Banafshe Felfeliyan1, Stephanie Wichuk2, Abhilash Hareendranathan3, Janet Ronsky4 and Jacob Jaremko2, 1University of Alberta, Calgary, AB, Canada, 2University of Alberta, Edmonton, AB, Canada, 3Radiology and Diagnostic Imaging, Edmonton, AB, Canada, 4University of Calgary, Calgary, AB, Canada

Meeting: ACR Convergence 2023

Keywords: Inflammation, Magnetic resonance imaging (MRI), Osteoarthritis, pain, Synovitis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 12, 2023

Title: Abstracts: Measures & Measurement of Healthcare Quality

Session Type: Abstract Session

Session Time: 2:00PM-3:30PM

Background/Purpose: Knee effusion-synovitis (ES) is an attractive target for therapeutic interventions in arthritis, since it is associated with stiffness, pain, and disease progression to arthroplasty. Rapid, objective methods to assess ES on MRI are desirable. Currently, ES is assessed by global user impression or semi-quantitative tools such MRI OA Knee Score (MOAKS); these approaches have high inter-user variability, are insensitive for change if categories are broad, or are time-consuming if scoring is detailed. To address these limitations, we have developed a novel deep learning (DL) approach to automatically measure ES volume (DL-ES), with high inter-rater reliability ICC=0.96 vs. human expert readers [1].

Here, we automatically generated ES volumes in a from a large subset of Osteoarthritis Initiative (OAI) dataset and assessed validity vs. other imaging scoring systems and clinical findings.

Methods: Total of 4659 MRIs from 1165 individuals with baseline (BL) and 1-year follow-up MOAKS and WOMAC scores were available from the OAI dataset. Scans were processed using a custom IMaskRCNN DL model, previously trained on 700 MRI slices with gold-standard effusion labels from an expert radiologist.

Cases with follow-up time>11 months, total WOMAC score >0, and KL grades < 4 were analyzed(n=656). Criterion validity of DL-ES was assessed through comparison of BL and 1-year change(Δ) in volume with MOAKS whole knee effusion and WOMAC scores via Kendall’s tau and Spearman rank correlation. Differences in DL-ES volumes between KL grades were evaluated via Kruskal-Wallis test.

Results: DL-EF calculation took 35 seconds/scan (Fig1). Median (IQR) baseline DL-ES volume was 19.8 (15.6-26.2) mL, with median (IQR) 1-year Δ of 1.3 (-2.1-5.3) mL. Median (IQR) DL-ES volume at BL increased significantly with BL KL Grade [17.3 (13.7-21.2) mL, 19.9 (15.8-26.0) mL, and 24.1 (18.4-31.9) mL for KL grades 1,2, and 3, respectively, p< 0.0001]. There was no significant difference in 1-year Δ in DL-ES between BL KL grades.

There was significant moderate positive correlation between DL-ES and MOAKS effusion BL and Δ scores [Kendall’s tau=0.27 (95% CI 0.21-0.32, p< 0.0001) and 0.30 (95% C 0.24-0.36, p< 0.0001), respectively].

DL-ES volumes showed a small significant positive correlation with WOMAC pain [Spearman’s rho=0.11 (95% CI 0.033-0.18, p=0.005) and 0.1 (95% CI 0.03-0.18, p=0.007) for BL and Δ, respectively], and WOMAC stiffness [Spearman’s rho= 0.08 (95% CI 0.01-0.16, p=0.03) and 0.11 (95% CI 0.04-0.19, p=0.004 for BL and Δ, respectively].

Conclusion: ES volume measured automatically using DL shows promising correlations to manual semiquantitative effusion scoring (MOAKS) and clinical features of knee arthritis (pain and stiffness). As others have found when measuring ES in other ways, we found higher (KL) grades (e.g., 3-4) were associated significantly with larger effusions. These results demonstrate validity of the proposed method for fully automated knee effusion quantification, which may ultimately prove useful in clinical care and clinical trials. [1] Felfeliyan et al., Improved-Mask R-CNN: Towards an accurate generic MSK MRI instance segmentation platform, CMIG 2022

Supporting image 1

Deep learning effusion segmentation result for one subject at baseline and follow-up

Supporting image 2

Deep-Learning Extracted Effusion-Synovitis Volume in cases with Kellgren-Lawrence Grades 1,2, and 3.

Supporting image 3

Kendall’s tau=0.30 (95% C 0.24-0.36, p<0.0001)


Disclosures: B. Felfeliyan: None; S. Wichuk: None; A. Hareendranathan: None; J. Ronsky: None; J. Jaremko: None.

To cite this abstract in AMA style:

Felfeliyan B, Wichuk S, Hareendranathan A, Ronsky J, Jaremko J. Validation of Quantitative Effusion-synovitis Volume Measured by Deep-learning: Data from the Osteoarthritis Initiative [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/validation-of-quantitative-effusion-synovitis-volume-measured-by-deep-learning-data-from-the-osteoarthritis-initiative/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/validation-of-quantitative-effusion-synovitis-volume-measured-by-deep-learning-data-from-the-osteoarthritis-initiative/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology